Event

Chronic obstructive pulmonary disease (COPD), the third leading cause of death in the United States, is a heterologous syndrome. The COPDGene study has created the largest cohort of well-characterized current and former smokers for respiratory disease research. The primary goals of COPDGene are: 1) to identify new genetic loci that influence the development of COPD and COPD-related phenotypes and 2) to reclassify COPD into subtypes that can ultimately be used to develop effective therapies. In this session, presenters will discuss new results from the COPDGene study, including protein biomarkers, genetics, and transcriptomics. In addition, presenters will discuss new insights that have developed from the COPDGene study into the diagnosis of prognosis of COPD patients.